NZ292417A - 7h-1,3-dioxolo[4,5-h] [2,3]-benzodiazepine derivatives and medicaments - Google Patents

7h-1,3-dioxolo[4,5-h] [2,3]-benzodiazepine derivatives and medicaments

Info

Publication number
NZ292417A
NZ292417A NZ292417A NZ29241795A NZ292417A NZ 292417 A NZ292417 A NZ 292417A NZ 292417 A NZ292417 A NZ 292417A NZ 29241795 A NZ29241795 A NZ 29241795A NZ 292417 A NZ292417 A NZ 292417A
Authority
NZ
New Zealand
Prior art keywords
compound
phenyl
solution
added
mixture
Prior art date
Application number
NZ292417A
Other languages
English (en)
Inventor
Benjamin Alan Anderson
Jeffrey T Vicenzi
David L Varie
Milton J Zmijewski
Marvin Martin Hansen
Nancy Kay Harn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ292417A publication Critical patent/NZ292417A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NZ292417A 1994-08-31 1995-08-30 7h-1,3-dioxolo[4,5-h] [2,3]-benzodiazepine derivatives and medicaments NZ292417A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US41302995A 1995-03-28 1995-03-28
PCT/US1995/010945 WO1996006606A1 (en) 1994-08-31 1995-08-30 Dihydro-2,3-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
NZ292417A true NZ292417A (en) 1998-09-24

Family

ID=26970798

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ292417A NZ292417A (en) 1994-08-31 1995-08-30 7h-1,3-dioxolo[4,5-h] [2,3]-benzodiazepine derivatives and medicaments

Country Status (12)

Country Link
US (1) US5795886A (enExample)
EP (3) EP1157992B1 (enExample)
JP (1) JP4131987B2 (enExample)
AT (2) ATE302779T1 (enExample)
CA (1) CA2198751C (enExample)
DE (2) DE69525342T2 (enExample)
DK (2) DK1157992T3 (enExample)
ES (2) ES2170804T3 (enExample)
FI (1) FI113049B (enExample)
NZ (1) NZ292417A (enExample)
PT (2) PT771198E (enExample)
WO (1) WO1996006606A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA972746B (en) * 1996-04-04 1998-10-09 Egyt Gyogyszervegyeszeti Gyar Novel 2,3-benzodiazepine derivatives
HUP9701325A1 (hu) * 1997-07-31 2000-08-28 Gyógyszerkutató Intézet Kft. Új 2,3-benzodiazepin-származékok
HU9803014D0 (en) * 1998-12-23 1999-02-01 Egyt Gyogyszervegyeszeti Gyar Novel phtalazine derivatives, process for their production and pharmaceutical compositions containing the same
HU227128B1 (en) * 1999-07-07 2010-07-28 Egyt Gyogyszervegyeszeti Gyar New 2,3-benzodiazepine derivatives
US6649607B2 (en) 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
US6858605B2 (en) * 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
TW200902024A (en) * 2007-04-02 2009-01-16 Teva Pharma Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
CU20090172A7 (es) 2009-10-09 2011-10-05 Ct De Investigación Y Desarrollo De Medicamentos Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
ES2244524T3 (es) 2005-12-16
EP1593683A2 (en) 2005-11-09
EP1157992A1 (en) 2001-11-28
EP0771198A4 (enExample) 1997-05-28
HK1013794A1 (en) 1999-09-10
FI970833L (fi) 1997-02-27
PT771198E (pt) 2002-06-28
DE69525342D1 (de) 2002-03-21
ATE302779T1 (de) 2005-09-15
US5795886A (en) 1998-08-18
FI113049B (fi) 2004-02-27
DK0771198T3 (da) 2002-04-22
EP1157992B1 (en) 2005-08-24
DE69534407D1 (de) 2005-09-29
JP4131987B2 (ja) 2008-08-13
CA2198751C (en) 2006-07-11
EP0771198A1 (en) 1997-05-07
JPH10505066A (ja) 1998-05-19
FI970833A0 (fi) 1997-02-27
WO1996006606A1 (en) 1996-03-07
ATE212994T1 (de) 2002-02-15
AU689639B2 (en) 1998-04-02
DE69534407T2 (de) 2006-03-16
ES2170804T3 (es) 2002-08-16
CA2198751A1 (en) 1996-03-07
EP1593683A3 (en) 2006-10-25
DE69525342T2 (de) 2002-11-07
AU3418695A (en) 1996-03-22
DK1157992T3 (da) 2005-10-24
EP0771198B1 (en) 2002-02-06
PT1157992E (pt) 2005-10-31

Similar Documents

Publication Publication Date Title
EP0771198B1 (en) Dihydro-2,3-benzodiazepine derivatives
US6288057B1 (en) Physical form of dihydro-2,3-benzodiazepine derivative
US5986114A (en) Benzopyranol derivatives
EP0699678B1 (en) Crystalline form of dihydro-2,3-benzodiazepine derivative
AU689639C (en) Dihydro-2,3-benzodiazepine derivatives
EP0699676B1 (en) Physical form of dihidro-2,3-benzodiazepine derivative
HK1086003A (en) Dihydro-2,3-benzodiazepine derivatives
HK1013794B (en) Dihydro-2,3-benzodiazepine derivatives
RU2146677C1 (ru) Физическая форма (r)-7-ацетил-5-(4-аминофенил)-8,9-дигидро-8-метил-7н-1,3- диоксоло[4,5-h]-[2,3]-бензодиазепина, способ ее получения и фармацевтическая композиция
HK1013819B (en) Physical form of dihidro-2,3-benzodiazepine derivative
HK1013820B (en) Crystalline form of dihydro-2,3-benzodiazepine derivative
US4594435A (en) Intermediates for 2'-substituted-spiro[benzofuran-2(3H),1'-cycloalkanes]

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired